BOLD: the balance sheet

MyFinsight

Boundless Bio, Inc. (BOLD)

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	17,483	17,868	14,980	14,697
Short-term investments	75,364	89,713	102,590	112,451
Prepaid expenses and other current assets	1,769	2,030	2,586	2,542
Total current assets	94,616	109,611	120,156	129,690
Total property and equipment	8,173	8,176	8,150	NaN
Less accumulated depreciation and amortization	5,233	4,960	4,651	NaN
Property and equipment, net	2,940	3,216	3,499	3,794
Right-of-use asset, net	42,831	43,659	44,480	45,365
Restricted cash	560	560	560	560
Other assets	23	13	26	44
Total assets	140,970	157,059	168,721	179,453

Accounts payable and accrued liabilities	5,710	6,727	6,773	5,855
Accrued compensation	589	2,643	2,020	1,397
Lease liabilities, current portion	3,284	3,167	3,052	1,961
Total current liabilities	9,583	12,537	11,845	9,213
Lease liabilities, non-current	45,004	45,868	46,707	47,549
Total liabilities	54,587	58,405	58,552	56,762
Common stock, 0.0001 par value 700,000 shares authorized, 22,407 shares issued and outstanding as of march 31, 2026 700,000 shares authorized, 22,407 shares issued and outstanding as of december 31, 2025	2	2	2	2
Additional paid-in-capital	359,628	358,257	356,901	355,598
Accumulated other comprehensive income (loss)	-23	64	50	-4
Accumulated deficit	-273,224	-259,669	-246,784	-232,905
Total stockholders' equity	86,383	98,654	110,169	122,691
Total liabilities and stockholders' equity	140,970	157,059	168,721	179,453

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.